Skip to main content

Asprosin Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-42216

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP3-42216

Key Product Details

Species Reactivity

Human, Porcine

Applications

Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.92 mg/ml

Product Specifications

Immunogen

Immunized with recombinant Human Asprosin (Uniprot#: P35555; Ser2732-His2871 (Uniprot#: P35555)

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for Asprosin Antibody

Asprosin Antibody

Immunohistochemistry-Paraffin: Asprosin Antibody [NBP3-42216] -

Immunohistochemistry-Paraffin: Asprosin Antibody [NBP3-42216] - DAB staining on IHC-P; Samples: Human Lung Tissue; Primary Ab: 20ug/ml NBP3-42216; Second Ab: 2ug/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody

Applications for Asprosin Antibody

Application
Recommended Usage

Immunocytochemistry/ Immunofluorescence

5-20ug/mL

Immunohistochemistry

5-20ug/mL

Western Blot

0.5-2ug/mL

Formulation, Preparation, and Storage

Purification

Antigen and protein A Affinity-purified

Formulation

0.01M PBS, pH7.4, 50% glycerol

Preservative

0.05% Proclin 300

Concentration

0.92 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: Asprosin

Alternate Names

FBN1, fibrillin 1

Gene Symbol

FBN1

Additional Asprosin Products

Product Documents for Asprosin Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Asprosin Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...